Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Barry I. Samuels
High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-Cvad Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
High-Dose Methotrexate With or Without Rituximab in Newly Diagnosed Primary CNS Lymphoma
Neurology
Neurology
Rituximab Plus ABVD in Newly Diagnosed Nodular Lymphocyte-Predominant Hodgkin Lymphoma
British Journal of Haematology
Hematology
VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B-Cell Lymphoma
American Journal of Hematology
Hematology
A PHASE 3 STUDY OF ACALABRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN ELDERLY (AGED ≥65 Years) TREATMENT-NAIVE PATIENTS WITH MANTLE CELL LYMPHOMA
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Five Years of Experience With Rituximab Plus High-Dose Dexamethasone for Relapsed/Refractory Chronic Lymphocytic Leukemia
Archives of Medical Science
Medicine
Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B- And T-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Treatment of Primary Mediastinal Large B Cell Lymphoma With an Alternating Chemotherapy Regimen Based on High-Dose Methotrexate
Annals of Hematology
Medicine
Hematology
Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma
British Journal of Haematology
Hematology
